These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The antiphospholipid syndrome in patients with systemic lupus erythematosus. Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934 [TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid Syndrome and the Kidney. Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550 [TBL] [Abstract][Full Text] [Related]
31. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
34. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
35. 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered. Islam MA; Alam F; Kamal MA; Wong KK; Sasongko TH; Gan SH CNS Neurol Disord Drug Targets; 2016; 15(10):1253-1265. PubMed ID: 27658514 [TBL] [Abstract][Full Text] [Related]
36. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes. Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535 [TBL] [Abstract][Full Text] [Related]
37. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems]. Zdrojewski Z Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350 [TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
39. Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome. Tektonidou MG; Sfikakis PP; Kolovou G; Mavrogeni S Mediterr J Rheumatol; 2018 Jun; 29(2):99-102. PubMed ID: 32185309 [TBL] [Abstract][Full Text] [Related]